IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AQST
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Aquestive Therapeutics Inc. stock upgraded to Hold/Accumulate.
(Updated on Apr 15, 2024)

Hold candidate since Apr 15, 2024 PDF

The Aquestive Therapeutics Inc. stock price gained 0.767% on the last trading day (Monday, 15th Apr 2024), rising from $3.91 to $3.94. During the last trading day the stock fluctuated 7.05% from a day low at $3.83 to a day high of $4.10. The price has been going up and down for this period, and there has been a -4.6% loss for the last 2 weeks. Volume fell on the last day by -2 million shares and in total, 1 million shares were bought and sold for approximately $5.28 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to rise 61.43% during the next 3 months and, with a 90% probability hold a price between $6.36 and $11.21 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

AQST Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aquestive Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.04 and $4.41. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -35.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Aquestive Therapeutics Inc. stock

Aquestive Therapeutics Inc. finds support from accumulated volume at $3.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.270 between high and low, or 7.05%. For the last week, the stock has had daily average volatility of 6.78%.

Our recommended stop-loss: $3.80 (-3.68%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 20 days ago.)

Trading Expectations (AQST) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Aquestive Therapeutics Inc. to open at $3.96, and during the day (based on 14 day Average True Range), to move between $3.56 and $4.32, which gives a possible trading interval of +/-$0.378 (+/-9.59%) up or down from last closing price. If Aquestive Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 19.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.91 (0.76%) than the resistance at $4.18 (6.09%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aquestive Therapeutics Inc. stock A Buy?

Aquestive Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.509 Hold/Accumulate Upgraded

Predicted Opening Price for Aquestive Therapeutics Inc. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$3.96 ( 0.423%) $3.94

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AQST

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.23 7.28 %
R2 4.12 4.66 %
R1 4.06 3.04 %
Current price: 3.94
Support S1 3.85 -2.19 %
S2 3.79 -3.81 %
S3 3.69 -6.43 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.51 14.34 %
R2 4.38 11.17 %
R1 4.18 6.09 %
Current price 3.94
Support S1 3.91 -0.761%
S2 3.65 -7.36%
S3 3.20 -18.78%

FAQ

What is the symbol for Aquestive Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aquestive Therapeutics Inc. is AQST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aquestive Therapeutics Inc. Stock?
Aquestive Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Aquestive Therapeutics Inc. Stock?
Aquestive Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aquestive Therapeutics Inc. Stock.

What's the current price of Aquestive Therapeutics Inc. Stock?
As of the end of day on the 2024-04-15, the price of an Aquestive Therapeutics Inc. (AQST) share was $3.94.

What is the 52-week high and low for Aquestive Therapeutics Inc. Stock?
The 52-week high for Aquestive Therapeutics Inc. Stock is $6.23 and the 52-week low is $1.16.

What is the market capitalization of Aquestive Therapeutics Inc. Stock?
As of the 2024-04-15, the market capitalization of Aquestive Therapeutics Inc. is 354.474M.

When is the next earnings date for Aquestive Therapeutics Inc.?
The upcoming earnings date for Aquestive Therapeutics Inc. is May 07, 2024.
Click to get the best stock tips daily for free!

About Aquestive Therapeutics Inc.

Aquestive Therapeutics. Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral ... AQST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT